Standard Biotools (LAB) Revenue Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 8.05% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | -10.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.10% |
| Mar 31, 2026 | -5.58% |
| Dec 31, 2025 | -4.15% |
| Sep 30, 2025 | -8.65% |
| Jun 30, 2025 | 5.04% |
| Mar 31, 2025 | -8.62% |
| Sep 30, 2024 | -37.92% |
| Jun 30, 2024 | -29.36% |
| Mar 31, 2024 | 11.57% |
| Dec 31, 2023 | -14.19% |
| Sep 30, 2023 | -13.99% |
| Jun 30, 2023 | 2.02% |
| Mar 31, 2023 | -3.11% |
| Dec 31, 2022 | -5.91% |
| Sep 30, 2022 | -1.08% |
| Jun 30, 2022 | -12.67% |
| Mar 31, 2022 | -4.16% |
| Sep 30, 2021 | 47.17% |
| Jun 30, 2021 | 34.16% |
| Mar 31, 2021 | 9.11% |